Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    4 0 0 0

Archives de pédiatrie
Volume 8, n° S4
pages 673-676 (septembre 2001)
Doi : S0929-693X(01)80181-0
Épidémiologie du purpura fulminans et recommandations thérapeutiques actuelles
Purpura fulminans: epidemiology and early therapeutic recommandations

P. Reinert
Service de pédiatrie, centre hospitalier intercommunal de Créteil, 40, avenue de Verdun, 94010 Créteil cedex, France 


Malgré les importants progrès de la réanimation pédiatrique, le taux de mortalité du purpura fulminans n'a pas diminué en France depuis 15 ans. Certaines études ont montré l'intérêt d'une antibiothérapie parentérale immédiate dès que le diagnostic est suspecté, aussi le Conseil supérieur d'hygiène publique de France, recommande à tous les praticiens, l'administration immédiate, de préférence en intraveineux, de ceftriaxone (IM, IV), de céfotaxime (IV) ou d'amoxicilline (IM, IV).

The full text of this article is available in PDF format.

Despite major advances in pediatics intensive care, meningococcemia remains an important cause of mortality en France (10 to 30%). Parenteral antibiotic given immediatly is associated with a substantial reduction in mortality. So the Conseil supérieur d'hygiène publique de France recommend that general practitioners should administrer promptly, preferably intraveinously, whenever purpura fulminans is suspected, ceftriaxone (IM, IV), cefotaxime (IV) or Amoxicillin (IM, IV).

The full text of this article is available in PDF format.

Mots-clé : épidémiologie / purpura fulminans / traitement

Keywords : child / clinical protocols / epidemiology / meningococcal infections / purpura

© 2001  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline